Cantor: Time To Buy StemCells By: Benzinga via Benzinga May 22, 2015 at 10:16 AM EDT In a report published Friday, Cantor Fitzgerald analysts initiated coverage of StemCells Inc (NASDAQ: STEM) with a Buy rating and a ... Read More >>